프리마켓
로그인 회원가입
CNXU
CNXU
Conexeu Sciences Inc
7월 27일 4:00 PM ET (한국 7/28 05:00)
$7.68
-0.89 ▼ -10.39%

코넥세우 사이언스(CNXU) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
시가총액
$206M
스몰캡
P/E
-
배당수익률
없음
52주 위치
0%
저점 -6% · 고점 -59%
애널리스트
적극 매수
C
Fundamental health
vs. Biotechnology· based on 1 axes
수익성
데이터 부족
성장
데이터 부족
밸류에이션
데이터 부족
재무 안정
Top 59%
Index -P/E -EPS (ttm) -Insider Own 57.94%Shs Outstand 26.8MPerf Week -13.51%
Market Cap 0.21BForward P/E -EPS next Y -Insider Trans 1.32%Shs Float 11.3MPerf Month -24.85%
Enterprise Value 0.20BPEG -EPS next Q -0.1Inst Own -Short Float 1.52%Perf Quarter -
Income -P/S -EPS this Y -Inst Trans -Short Ratio 1.68Perf Half Y -
Sales -P/B 28.56EPS next 5Y -ROA -Short Interest 0.17MPerf YTD -43.11%
Book/sh 0.27P/C 28.15EPS past 3/5Y -950.49% -ROE -52W High -59.13% ($18.79)Perf Year -
Cash/sh 0.27P/FCF -Sales past 3/5Y -ROIC -52W Low -5.65% ($8.14)Perf 3Y -
Dividend Est. -EV/EBITDA -EPS Y/Y TTM -Gross Margin -Volatility(W/M) 11.47% 13.77%Perf 5Y -
Dividend TTM -EV/Sales -Sales Y/Y TTM -Oper. Margin -ATR (14) 1.5Perf 10Y -
Dividend Ex-Date -Quick Ratio 7.89EPS Q/Q -519.42%Profit Margin -RSI (14) 36.76Recom 1
Dividend Gr. 3/5Y -Current Ratio 7.89Sales Q/Q -SMA20 -22.25% ($9.88)Beta -Target Price $20
Payout -Debt/Eq 0Earnings 2026/07/01SMA50 -34% ($11.64)Rel Volume 1.38Prev Close $8.57
Employees 4LT Debt/Eq 0EPS/Sales Surpr. -SMA200 -34% ($11.64)Avg Volume(3M) 0.10MPrice $7.68
IPO 2026/5/21Option/Short No/YesTrades 2053Volume 140,530Change -10.39%

📊 Conexeu Sciences Inc (CNXU) Investment Analysis

What kind of company is Conexeu Sciences Inc?

코넥세우 사이언스(CNXU)
Healthcare · Biotechnology
Small-Cap — Low Volume, High Volatility

🧬 Connexios Sciences (CNXU) is a U.S. clinical-stage biotechnology company that develops bio-regenerative scaffolds for wound healing, dental tissue regeneration, and cosmetic/aesthetic applications, based on its proprietary extracellular matrix platform technology.

Learn more about Conexeu Sciences Inc →
Market Cap
$0.2B
Approx. KRW 0.3 trillion
⚖️ 0% of Samsung Electronics
Market Cap Rank4058
Employees4people
IPO2026/05/21
Current Price$7.68 ≈ 10,522원
NASD · USA

Key Events

⏰ Upcoming events
🔔 Earnings release
The next release date has not been announced yet.
🎯 Ex-dividend date
No scheduled dividends
📜 Recent events
🔔 Earnings release 2026년 7월 1일 (수) · 장 마감 후 EPS +0.0%
🔔 Earnings release 2026년 4월 1일 (수) · 장 마감 후

Is it profitable?

Financial health solid
Financial health — Debt & liquidity burden
Debt-to-Equity (D/E)
Debt relative to equity (lower is healthier)
0.00
✓ Very low debt
My positionTop 5%
Low range Average High range
Biotechnology Median 0.05
💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)
Current Ratio
Liquid assets available to cover liabilities due within a year
7.89
✓ 양호
My positionMid-range
Low range Average High range
Biotechnology Median 5.75
💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의
Quick Ratio
Liquid assets excluding inventory, available for immediate use
7.89
✓ 양호
My positionMid-range
Low range Average High range
Biotechnology Median 5.47
💡 1.0 이상이면 안전, 0.5 미만이면 주의
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Mixed Outlook
Positive and negative signals are mixed
애널리스트 목표가
$20.00
현재가 대비 +160.4%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

Average Earnings Performance
Generally in line with estimates
0
예상 상회
1
예상 부합
0
예상 하회
0%
상회 비율
+0.0%
평균 서프라이즈
2026.07.01
부합
+0.0%
💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.

Is it growing?

Average Growth
Mid-range within the industry
📊 How much has it grown? (actual results)
Past 3-Year EPS
Actual average annual EPS growth over the past 3 years
-950.5%
매우 부진
My positionBottom 5%
Low range Average High range
미분류 초소형주 Median 25.4% · Bottom tier
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

Has the stock risen over the long term?

Returns by period
Current position within 52-week range
Low (-5.7%p) High (-59.1%p)
Current price is 5.7% above the 52-week low and 59.1% below the 52-week high
Recent risk (last 44 trading days)
Max drawdown
-54.4%
Annualized volatility
133.7%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 45-day series

Price · Bollinger Bands · Ichimoku Cloud

  • close
  • BB Upper
  • BB Mid
  • BB Lower
  • Tenkan
  • Kijun
  • Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔵
Current diagnosis · 2026-07-27
Oversold zone — rebound potential

Current price $7.68 fell below the lower band ($8.18). Selling pressure excessive; worth watching for a short-term bounce.

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

Current diagnosis · 2026-07-27
Death cross — bearish reversal signal

MACD(-1.005) crossed below Signal(-0.956). Trend reversal possible; read as a sell entry point.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴
Current diagnosis · 2026-07-27
Bearish zone

RSI 36.9 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 6.0.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Pricier than peers in its industry
Pricey on Vs. Assets
💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.
🏢 Vs. Assets Pricey
🏢 Vs. Assets
PBR Price-to-Book Ratio
Price vs. the company's asset value — below 1 trades cheaper than assets
28.56x
✓ Very pricey
My positionBottom 5%
Low range Average High range
Biotechnology 초소형주 median 1.35x · Bottom 1% — expensive within the industry
💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)
Analyst target price (reference)
$20.00 vs. current price +160.4%
* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.
As of: Recent snapshot · Peer group: Biotechnology 초소형주

Who owns it?

Ownership flow is positive
Insider modest net buying +1.3% · Short interest light 1.5% · Short interest up +1.2pp over last 31d
📈 Recent trading flow (6 months)
🧑‍💼 Insiders (executives & directors)
+1.3%
Insiders net buying
🏦 Institutions (funds & investors)
-
No trading data for Institutions
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🧑‍💼 Insiders 57.9%
Founder/management large holders (strong skin-in-the-game)
Healthcare 초소형주 Median 16.1%
👤 Retail investors (estimated) 42.1%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
1.5%
Low — limited short-side pressure
Healthcare 초소형주 Median 3.9%
Past 31 days 📈 +1.2%p increase
Short interest days to cover
1.7 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 26.8M주
Float (tradable shares) 11.3M주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 31 days.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
StockMarket CapPERPBRROEDividend YieldChange
CNXU CNXU This Stock
$205.5M- 28.6 - - -10.4%
LLY
$1.13T43.1 36.2 107.64% 0.58% +0.1%
JNJ
$640.9B30.8 7.5 25.74% 2.02% +1.0%
ABBV
$453.9B126.7 - 15221.82% 2.67% -0.9%
UNH
$379.3B26.9 3.9 12.49% 2.16% -0.7%
MRK
$323.0B36.8 7.0 18.97% 2.5% -0.2%
Sector Avg-26.12.7-48.83%1.23%-
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen

FAQ

What kind of company is 코넥세우 사이언스(CNXU)?

코넥세우 사이언스(CNXU) belongs to the Healthcare sector and operates in the Biotechnology industry.

What is the market cap of CNXU?

The market cap of CNXU is approximately $206M, ranking 4,058 within its sector.

What is the 52-week high and low for CNXU?

CNXU has recorded a 52-week high of $18.79 and a low of $8.14.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.